Cargando…

Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer

Background: Bladder cancer (BLCA) is highly heterogeneous with distinct molecular subtypes. This research aimed to investigate the heterogeneity of different molecular subtypes from a tumor microenvironment perspective and develop a molecular-subtype-associated immune prognostic signature that can b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shenghua, Chen, Haotian, Zheng, Zongtai, He, Yanyan, Yao, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045524/ https://www.ncbi.nlm.nih.gov/pubmed/36978709 http://dx.doi.org/10.3390/bioengineering10030318

Ejemplares similares

CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2022)

Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients
por: Li, Zi-zhuo, et al.
Publicado: (2021)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma
por: Chang, Feng-Chi, et al.
Publicado: (2021)

Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer
por: Fan, Ming, et al.
Publicado: (2017)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes
por: Huang, Chao, et al.
Publicado: (2019)

Molecular subtypes, tumor microenvironment infiltration characterization and prognosis model based on cuproptosis in bladder cancer
por: Zhang, Heping, et al.
Publicado: (2023)

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1
por: Rathore, Saima, et al.
Publicado: (2018)

Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
por: Bao, Dan, et al.
Publicado: (2021)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature
por: Fan, Tingting, et al.
Publicado: (2022)

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma
por: Sun, Chen, et al.
Publicado: (2022)

MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
por: Ming, Xue, et al.
Publicado: (2019)

Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning
por: Sheng, Weiyong, et al.
Publicado: (2022)

Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
por: Wu, Shaoxu, et al.
Publicado: (2018)

Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures
por: Huang, Xiaoli, et al.
Publicado: (2020)

Radiomics feature robustness as measured using an MRI phantom
por: Lee, Joonsang, et al.
Publicado: (2021)

Machine Learning Based on MRI DWI Radiomics Features for Prognostic Prediction in Nasopharyngeal Carcinoma
por: Hu, Qiyi, et al.
Publicado: (2022)

MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures
por: Corti, Anna, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of the Urinary Bladder: CT Findings and Radiomics Signature
por: Coppola, Andrea, et al.
Publicado: (2023)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Repeatability of Multiparametric Prostate MRI Radiomics Features
por: Schwier, Michael, et al.
Publicado: (2019)

Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients
por: Yan, Jing, et al.
Publicado: (2021)

MRI-Based Radiomics in Bladder Cancer: A Systematic Review and Radiomics Quality Score Assessment
por: Boca, Bianca, et al.
Publicado: (2023)

Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases
por: Fan, Ying, et al.
Publicado: (2022)

PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer
por: Shen, Liliang, et al.
Publicado: (2022)

Multiparametric MRI Features of Breast Cancer Molecular Subtypes
por: Szep, Madalina, et al.
Publicado: (2022)

A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
por: Chen, Runpu, et al.
Publicado: (2022)

Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
por: Zhang, Baihua, et al.
Publicado: (2021)

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer
por: Li, Huanhuan, et al.
Publicado: (2021)

Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer
por: Tang, Xing, et al.
Publicado: (2020)

Can Only the Shape Feature in Radiomics Help Machine Learning Show That Bladder Cancer Has Invaded Muscles?
por: Özdemir, Harun, et al.
Publicado: (2023)

MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes
por: Bretzner, Martin, et al.
Publicado: (2021)

Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set
por: Li, Hui, et al.
Publicado: (2016)

Radiomic Analysis of Quantitative T2 Mapping and Conventional MRI in Predicting Histologic Grade of Bladder Cancer
por: Ye, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3mi9gpks54qbehkdvturn61ptv